Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2000
11/22/2000EP1052989A1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052982A1 AMINOTETRALINS AS 5-HT 1D$g(a)? AGONISTS
11/22/2000EP1052975A1 Propofol composition containing sulfite
11/22/2000EP0736012B1 Anellated dihydropyridines and their use in the production of pharmaceutical preparations
11/22/2000EP0699180B1 Bicyclic amide derivatives and their use as muscle relaxants
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000EP0586535B1 Methods and compositions based on inhibition of cell invasion and fibrosis by dextran sulfate
11/22/2000CN1274357A Antipsychotic substituted piperidine derivatives
11/22/2000CN1274353A Halogen substituted tetracyclic tetrahydrofuran derivatives
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274286A Parenteral formulations comprising carbamazepine or its derivatives
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1273967A Novel substituted dimeric compounds, its preparing process and medicinal compsns. containing same
11/22/2000CN1273861A Low sustituted ethylene-lactic cellulose and solid preparation
11/22/2000CN1273859A Buccal lozenge for activating intelligent genes and increasing intelligence quotient
11/22/2000CN1058614C Galenic prepn. compsn.
11/21/2000US6150557 Compounds
11/21/2000US6150524 Morphine derivatives with analgesic activity
11/21/2000US6150417 Administering to warm blooded animals compounds such as n-tert-butyl-5-((2-(2-methoxyphenoxy)ethyl)amino)pentanamide for inducing antiemetic activity; treating anxiety, depression, and sleep disorders
11/21/2000US6150416 2-hydroxy-3-(substitued benzyl)-n,n'-bis(substituted carbonyl)-n-(substituted)-1,3-propanediamine based compounds; use in the detection, labelling and inhibition of cathepsin d
11/21/2000US6150412 Such as 4-(5-hydroxy-4-methoxy-2-nitrophenyl)butanoic acid; administering to inhibit catechol-o-methyl transferase; treating parkinson's disease or hypertension
11/21/2000US6150411 Treating dyslexia by administering to a subject docosahexaenoic acid (dha)
11/21/2000US6150393 N-(3-(4-bromo-1-methylpyrazol-3-yl)phenyl)(phenylmethylamino) -carboxamide modifier of activity of the serotonin 5-ht 2a; cns, gastrointestinal and cardiovascular disorders; antiinflammatory agents; side effect reduction
11/21/2000US6150391 Subtype-selective 5-ht1d receptor agonists having a human 5-ht1d alpha receptor binding affiity; treatment of migraine, cluster headache, chronic paroxysmal hemicrania, vascular headache, tension headache, and pediatric migraine
11/21/2000US6150389 Antidepressants; treating elevated intraocular pressure, e.g., glaucoma; antidiabetic agents for non-insulin dependent diabetes, sexual disorders, e.g., male impotence and obesity; e.g. trans-2-(3-phenyl-bicyclo(2.2.1)heptyl)-2-aminooxazoline
11/21/2000US6150388 Indole derivatives as 5-HT1 agonists
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150376 Bi- and tri-cyclic aza compounds and their uses
11/21/2000US6150373 Bicyclic nitrogen heterocycles
11/21/2000US6150366 Crystalline ziprasidone free base or crystalline ziprasidone hydrochloride particles with specific particle size are useful as antipsychosis agent
11/21/2000US6150365 Anxiety method
11/21/2000US6150358 Useful in the treatment of disease for which the use of anti-oxidation agent is requiered such as neurodegenrative disorders
11/21/2000US6150352 Antagonists of gonadotropin releasing hormone
11/21/2000US6150349 Methods for treating psychosis associated with glucocorticoid related dysfunction
11/21/2000US6150345 Methods for promoting survival of myelin producing cells
11/21/2000US6150335 Treatment for pain
11/21/2000US6150326 Means for treating autoimmune diseases and method for the treatment thereof
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000US6150091 Direct molecular diagnosis of Friedreich ataxia
11/21/2000CA2187309C Tropane-2-aldoxime derivatives as neurotransmitter reuptake inhibitors
11/21/2000CA2093433C Sertindole prodrugs
11/21/2000CA2081482C Method and composition for treatment of central nervous system disease states associated with abnormal amyloid beta protein molecular organization
11/21/2000CA2031150C Sustained-release drug dosage units
11/16/2000WO2000068691A1 Methods for screening gaba-modulatory compounds for specified pharmacological activities
11/16/2000WO2000068387A2 Nucleic acids and proteins with interferon-beta activity
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068267A1 LOW-DOSE IL-1β-INDUCED PHOTORECEPTOR CELL RESCUE WITHOUT RETINAL DYSPLASIA
11/16/2000WO2000068266A1 Amyloid precursor protein protease and related nucleic acid compounds
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068254A1 Spray drying of thrombin inhibitors
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068215A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068208A1 Pyrimidinones derivatives for the treatment of atherosclerosis
11/16/2000WO2000068206A1 Heterocyclically substituted benzimidazoles, the production and application thereof
11/16/2000WO2000068202A1 Substituted 4-oxo-quinoline-3-carboxamides: gaba brain receptor ligands
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000068184A1 Aromatic amides
11/16/2000WO2000068183A2 High purity (1r,2s,4r)-(-)-2-[(2'-{n,n-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1]heptane and pharmaceutically acceptable acid addition salts thereof, process for the preparation of these compounds and medicaments containing them
11/16/2000WO2000068181A2 Process for preparing (1r,2s,4r) -(-)-2-[(2'- {n,n-dimethylamino} -ethoxy)] -2-[phenyl] -1,7,7-tri- [methyl] -bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067791A1 Ccr4 antagonists in sepsis
11/16/2000WO2000067777A1 A method of prophylaxis and treatment and agents useful therefor
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067755A1 Cyclic amidines useful as nmda nr2b antagonists
11/16/2000WO2000067753A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate)
11/16/2000WO2000067752A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation
11/16/2000WO2000067751A1 Aryl amidines, compositions containing such compounds and methods of use
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067744A1 Neuroprotective composition and uses thereof
11/16/2000WO2000067739A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects
11/16/2000WO2000067734A2 Use of phthalazine derivatives
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067697A2 Nucleic acid-antibody conjugate for delivering a foreign nucleic acid in cells
11/16/2000WO2000067696A2 Lactic acid bacteria with anxiolytic properties and uses thereof
11/16/2000WO2000056336A3 Pharmaceutical compositions comprising a pyrimidine derivative and cyclodextrin
11/16/2000WO2000042191A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/16/2000WO2000042179A3 Complex-forming proteins
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000037059A3 Compositions and methods to inactivate n-type calcium channels
11/16/2000WO2000034511A3 Aβ-PEPTIDE SCREENING ASSAY
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000027846A3 Crf receptor antagonists and methods relating thereto
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026370A3 Adenine nucleotide translocator (ant) fusion proteins and uses thereof
11/16/2000WO2000020448A3 Nlk1 -interacting proteins
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000WO2000009549A3 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use
11/16/2000WO2000009103A3 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders
11/16/2000WO2000006138A3 Use of moclobemide for treating pain and other diseases
11/16/2000WO2000005375A9 Gbs toxin receptor
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines
11/16/2000DE19921346A1 Sprühtrocknung von Thrombininhibitoren Spray drying of thrombin inhibitors
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
1 ... 1473 1474 1475 1476 1477 1478 1479 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 ... 1833